KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Synopsys (SNPS) Research & Development (2016 - 2026)

Synopsys (SNPS) has disclosed Research & Development for 18 consecutive years, with $715.0 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 29.24% year-over-year to $715.0 million, compared with a TTM value of $2.6 billion through Jan 2026, up 25.17%, and an annual FY2025 reading of $2.5 billion, up 19.06% over the prior year.
  • Research & Development was $715.0 million for Q1 2026 at Synopsys, down from $746.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $746.8 million in Q4 2025 and bottomed at $371.1 million in Q4 2022.
  • Average Research & Development over 5 years is $514.1 million, with a median of $507.4 million recorded in 2023.
  • The sharpest move saw Research & Development decreased 10.34% in 2022, then soared 34.61% in 2025.
  • Year by year, Research & Development stood at $371.1 million in 2022, then grew by 25.53% to $465.8 million in 2023, then rose by 19.11% to $554.8 million in 2024, then skyrocketed by 34.61% to $746.8 million in 2025, then dropped by 4.27% to $715.0 million in 2026.
  • Business Quant data shows Research & Development for SNPS at $715.0 million in Q1 2026, $746.8 million in Q4 2025, and $625.3 million in Q3 2025.